Advancements in Treating Chemotherapy Side Effects – A New Standard of Care for Preventing Hand-Foot Syndrome – Igryl S. Cordero, MD

Patients undergoing treatment for breast or gastrointestinal cancers with the chemotherapy drug capecitabine (Xeloda®) may develop hand-foot syndrome (HFS). A common treatment side-effect, HFS can lead to redness, swelling, skin peeling, and sometimes painful blisters on the palms and soles. Although the syndrome is not life-threatening, it can cause significant discomfort and negatively impact a […]

Investigational Inhibitor of Active RAS Shows Clinical Promise – Alexander I. Spira, MD, PhD, FACP

Investigational Inhibitor of Active RAS Shows Clinical Promise –  The therapy uses a different mechanism than approved KRAS G12C inhibitors and targets multiple RAS mutations beyond KRAS G12C  

Multiple Myeloma Research Foundation (MMRF) – Team Virginia Cancer Specialists!

This past Saturday, September 30, 2023 – Honorary Event Chair Dipti Patel-Donnelly, MD and Team Virginia Cancer Specialists participated in the Multiple Myeloma Research Foundation (MMRF) 5K Run/Walk at the National Harbor. The Walk raises money and brings a smarter, faster cure to every multiple myeloma patient. This year, team Virginia Cancer Specialists raised $6,000! […]